Clozapine reduces rehospitalization among schizophrenia patients

Psychopharmacology Bulletin

Volumn 34, Issue 1, 1998, Pages 89-92

  Pollack, Simcha ^a,b   Woerner, Margaret G ^a,c   Howard, Alfreda ^a   Fireworker, Robert B ^b   Kane, John M ^a,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Clozapine; Cost effectiveness; Pharmacoeconomics; Rehospitalization; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MALE; RECURRENCE; SCHIZOPHRENIA;

EID: 0031902569     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Davies, LM, and Drummond, MF. Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. Br. J. Psychiatry 162:38-42, 1993.
2. Essock, SM; Hargreaves, WA; Dohm, F-A; Goethe, J; and Hipshman, L. Clozapine eligibility among state hospital patients. Schizophr. Bull. 22(1):15-25, 1996.
3. Honigfeld, G, and Patin, J. A two-year clinical and economic follow-up of patients on clozapine. Hosp. Community Psychiatry 41:882-885, 1990.
4. Kane, JM; Honigfeld, G; Singer, J; Meltzer, HY; and the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45:789-796, 1988.
5. Meltzer, HY; Cola, P; Way, L; Thomson, PA; Bastani, B; Davies, MA; and Smitz, B. Cost-effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am. J. Psychiatry 150:1630-1638, 1993.
6. Meltzer, HY, and Cola, PA. The pharmacoeconomics of clozapine: A review. J. Clin. Psychiatry 55(Suppl. B):161-165, 1994.
7. Reid, WH; Mason, M; and Toprac, M. Savings in hospital bed-days related to treatment with clozapine. Hosp. Community Psychiatry 45:261-264, 1994.
8. Revicki, DA; Luce, BR; Weschler, JM; Brown, RE; and Adler, MA. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hosp. Community Psychiatry 41:850-854, 1990.